Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710
Addition of an Author
- Simona Sennato 1,†, Giorgia Paldino 2,†, Cecilia Bombelli 3, Irene Mezzani 2, Stefania Petrini 2, Eugenia Belcastro 2, Domenico Vittorio Delfino 4, Francesco Fiorentino 5, Carlotta Marianecci 5, Alessia Ciogli 5, Dante Rotili 6, Francesca Ceccacci 3,* and Alessandra Fierabracci 2,*
- 2
- Bambino Gesù Children’s Hospital, Istituto di Ricovero e Cura a Carattere Scientifico (IRCCS), 00146 Rome, Italy; giorgiapld@gmail.com (G.P.); irene.mezzani@opbg.net (I.M.); stefania.petrini@opbg.net (S.P.); eugenia.belcastro@unipi.it (E.B.)
- Author Contributions: Conceptualization, F.C., S.S., C.B., D.V.D., D.R. and A.F.; methodology, G.P., F.C., S.P., I.M., S.S., C.B., F.F., E.B. and A.F.; investigation, G.P., F.C., I.M., S.S., C.B., F.F., C.M., A.C., D.R. and A.F.; data curation, F.C., S.P., S.S., C.B., C.M. and A.C.; writing—original draft preparation, F.C., S.S., C.B. and A.F.; writing—review and editing, A.F. and F.C.; supervision, A.F.; project administration, A.F.; funding acquisition, A.F. All authors have read and agreed to the published version of the manuscript.
Reference
- Sennato, S.; Paldino, G.; Bombelli, C.; Mezzani, I.; Petrini, S.; Belcastro, E.; Delfino, D.V.; Fiorentino, F.; Marianecci, C.; Ciogli, A.; et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Sennato, S.; Paldino, G.; Bombelli, C.; Mezzani, I.; Petrini, S.; Belcastro, E.; Delfino, D.V.; Fiorentino, F.; Marianecci, C.; Ciogli, A.; et al. Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics 2025, 17, 1601. https://doi.org/10.3390/pharmaceutics17121601
Sennato S, Paldino G, Bombelli C, Mezzani I, Petrini S, Belcastro E, Delfino DV, Fiorentino F, Marianecci C, Ciogli A, et al. Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics. 2025; 17(12):1601. https://doi.org/10.3390/pharmaceutics17121601
Chicago/Turabian StyleSennato, Simona, Giorgia Paldino, Cecilia Bombelli, Irene Mezzani, Stefania Petrini, Eugenia Belcastro, Domenico Vittorio Delfino, Francesco Fiorentino, Carlotta Marianecci, Alessia Ciogli, and et al. 2025. "Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710" Pharmaceutics 17, no. 12: 1601. https://doi.org/10.3390/pharmaceutics17121601
APA StyleSennato, S., Paldino, G., Bombelli, C., Mezzani, I., Petrini, S., Belcastro, E., Delfino, D. V., Fiorentino, F., Marianecci, C., Ciogli, A., Rotili, D., Ceccacci, F., & Fierabracci, A. (2025). Correction: Sennato et al. Optimization of Lipoplexes Functionalized with a Sialic Acid Mimetic (F9-PEG) to Target the C1858T PTPN22 Variant for Preclinical Assessment of a Novel Immunotherapy in Endocrine Autoimmunity. Pharmaceutics 2025, 17, 710. Pharmaceutics, 17(12), 1601. https://doi.org/10.3390/pharmaceutics17121601

